Researchers from Southern Medical University and collaborators report the identification of FDA‑approved compounds that may lower blood lipids by combining computational screening with clinical and ...
In this new article publication from Acta Pharmaceutica Sinica B, authors Wei Wang, Shuo Feng, Zhuyifan Ye, Hanlu Gao, Jinzhong Lin and Defang Ouyang from University of Macau, Macau, China and Fudan ...
Experts from the LNP Alliance discuss where LNP programs stall, how the field is moving beyond vaccines, and why translation ...
In a breakthrough for cardiovascular medicine, researchers have harnessed artificial intelligence to discover unexpected lipid-lowering effects in existing FDA-approved drugs. The study, published in ...
Primary care prescribing data shows that the prescribing of low- and medium-intensity statins across BOB significantly reduced during the scheme period, which continues to be sustained. See ...
Primary care prescribing data shows that the prescribing of low- and medium-intensity statins across BOB significantly reduced during the scheme period, which continues to be sustained. See ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results